Hepatitis B vaccination in uremic patients: comparison between recombinant and plasma-derived vaccine.
The immune response to recombinant and plasma-derived vaccines was evaluated in 53 and 43 uremic patients, respectively. The total rate of seroconversion was around 80% with both vaccines, although a significantly higher response was obtained with the protocol using recombinant vaccine.
Bergia
R
R
Servizio di Nefrologia e Dialisi, Ospedale degli Infermi, Biella, Italy.
Pellerey
M
M
Berto
I
I
Caramello
E
E
Dionisio
P
P
Valenti
M
M
Converso
C
C
Garbaccio
G
G
Bajardi
P
P
D000368:Aged; D005260:Female; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines; D006801:Humans; D008297:Male; D008875:Middle Aged; D014511:Uremia / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000627:therapeutic use; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines